Pharmaceutical News

RSS

New polyclonal immunotherapy successfully neutralizes Ebola virus

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided "100% protection against a lethal dose of the Ebola virus" in a recent animal study published in The Journal of Infectious Diseases.

15 Aug 2018

Powerful psychedelic compound can model near-death experiences in the brain

A powerful psychedelic compound found in ayahuasca can model near-death experiences in the brain, a study has found.

15 Aug 2018

Johns Hopkins expert panel develops first set of operation-specific opioid prescribing guidelines

A Johns Hopkins expert panel of health care providers and patients have announced what is, to their knowledge, the nation's first set of operation-specific opioid prescribing guidelines.

14 Aug 2018

New digital pharmacy aims to help people living with chronic care conditions

Thirty jobs are to be created through a new £1.5m ‘Tele-Pharmacy’opening in Liverpool, aimed at helping people living with chronic care conditions to manage their medicinal needs through the UK’s only artificial intelligent mobile app ‘Now Patient’.

From Infohealth Ltd 14 Aug 2018

NIH grant for Mount Sinai to study use of inhaled corticosteroids for treatment of sickle cell disease

The Departments of Emergency Medicine and Hematology at the Icahn School of Medicine at Mount Sinai have been awarded a $4 million grant from the National Institutes of Health toward further study of inhaled corticosteroids to treat sickle cell disease in individuals who do not have asthma.

14 Aug 2018

Using peripheral nerve blocks to treat facial pain may produce long-term pain relief

A new study has shown that use of peripheral nerve blocks in the treatment of Trigeminal Neuralgia may produce long-term pain relief.

14 Aug 2018

New strategy accelerates, automates process of prototype molecule optimization

The search for new medicinal molecules with predetermined properties is a rather complex, expensive and time-consuming process, especially in oncology.

14 Aug 2018

Researchers develop new way of testing bacterial resistance to antibiotics

A new method to analyze a commonly understood route for antibiotic resistance could lead to earlier detection of antibiotic resistant bacteria.

14 Aug 2018

Mono-antiplatelet therapy after aortic heart valve replacements may work as well as two drugs

Current treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots.

14 Aug 2018

OncoThira and NDSU enter into license agreement to develop, market cancer compounds

The NDSU Research Foundation and OncoThira have entered into a license agreement involving technology developed at North Dakota State University.

14 Aug 2018

Long-term cannabinoid exposure impairs memory, study shows

A new study led by Ana Sebastião, group leader at Instituto de Medicina Molecular João Lobo Antunes and Professor of Faculdade de Medicina of Universidade de Lisboa and her team in collaboration with researchers from the University of Lancaster, shows that the long-term use of either cannabis or cannabis-based drugs impairs memory.

13 Aug 2018

Study: Patients taking OTC drugs, dietary supplements not aware of effects on lab test results

Over-the-counter drugs and dietary supplements are widely used and popular, with US households spending an average of almost USD 350 annually on OTC products. In 2006 an average of EUR 67.50 was spent per person on OTC products in Germany.

13 Aug 2018

Study may help increase effectiveness of antibiotics against drug-resistant bacteria

Bacteria - especially Gram-negative strains - are becoming increasingly resistant to current antibiotic drugs, and the development of new classes of antibiotics has slowed.

13 Aug 2018

Study shows link between use of benzodiazepines and increased risk of Alzheimer's disease

The use of benzodiazepines and related drugs (Z drugs) is associated with a modestly increased risk of Alzheimer's disease, according to a recent study from the University of Eastern Finland.

13 Aug 2018

FDA approves first oral medication for treatment of adults with Fabry disease

The U.S. Food and Drug Administration today approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.

10 Aug 2018

Study finds prevalence of substandard and falsified medicines in developing countries

A new study from the University of North Carolina at Chapel Hill found that substandard and falsified medicines, including medicines to treat malaria, are a serious problem in much of the world.

10 Aug 2018

FDA approves first vaginal ring contraceptive that can be used for one year

The U.S. Food and Drug Administration today approved Annovera (segesterone acetate and ethinyl estradiol vaginal system), which is a combined hormonal contraceptive for women of reproductive age used to prevent pregnancy and is the first vaginal ring contraceptive that can be used for an entire year.

10 Aug 2018

Psychedelics may one day be used to treat mental health disorders

Many people think of psychedelics as relics from the hippie generation or something taken by ravers and music festival-goers, but they may one day be used to treat disorders ranging from social anxiety to depression, according to research presented at the annual convention of the American Psychological Association.

10 Aug 2018

FDA approves first targeted RNA-based treatment for rare, fatal genetic disease

The U.S. Food and Drug Administration today approved Onpattro (patisiran) infusion for the treatment of peripheral nerve disease (polyneuropathy) caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adult patients.

10 Aug 2018

PARP inhibitors show promise for treating and preventing brain disorders

A class of cancer drugs called PARP inhibitors could be useful for treating and preventing brain disorders, including amyotrophic lateral sclerosis, also called Lou Gehrig's disease, and some forms of frontotemporal degeneration, by halting the misplacement of specific proteins that affect nerve cells, according to a study published in Molecular Cell by researchers in the the School of Arts and Sciences and the Perelman School of Medicine at the University of Pennsylvania.

10 Aug 2018

Pharmaceutical News

New polyclonal immunotherapy successfully neutralizes Ebola virus

Powerful psychedelic compound can model near-death experiences in the brain

Johns Hopkins expert panel develops first set of operation-specific opioid prescribing guidelines

New digital pharmacy aims to help people living with chronic care conditions

NIH grant for Mount Sinai to study use of inhaled corticosteroids for treatment of sickle cell disease

Using peripheral nerve blocks to treat facial pain may produce long-term pain relief

New strategy accelerates, automates process of prototype molecule optimization

Researchers develop new way of testing bacterial resistance to antibiotics

Mono-antiplatelet therapy after aortic heart valve replacements may work as well as two drugs

OncoThira and NDSU enter into license agreement to develop, market cancer compounds

Long-term cannabinoid exposure impairs memory, study shows

Study: Patients taking OTC drugs, dietary supplements not aware of effects on lab test results

Study may help increase effectiveness of antibiotics against drug-resistant bacteria

Study shows link between use of benzodiazepines and increased risk of Alzheimer's disease

FDA approves first oral medication for treatment of adults with Fabry disease

Study finds prevalence of substandard and falsified medicines in developing countries

FDA approves first vaginal ring contraceptive that can be used for one year

Psychedelics may one day be used to treat mental health disorders

FDA approves first targeted RNA-based treatment for rare, fatal genetic disease

PARP inhibitors show promise for treating and preventing brain disorders

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News